A patient with acute leukemia recently underwent allogenic bone marrow transplantation. After 2 weeks, she was neutropenic and developed a fever and cough. She was diagnosed with i... A patient with acute leukemia recently underwent allogenic bone marrow transplantation. After 2 weeks, she was neutropenic and developed a fever and cough. She was diagnosed with invasive aspergillosis based on radiological and microbiological assessment. Which of the following is the most appropriate treatment? A. Rifampicin B. Valaciclovir C. Tigecycline D. Voriconazole
Understand the Problem
The question is asking which treatment is most appropriate for a patient with invasive aspergillosis after undergoing an allogeneic bone marrow transplantation. The key details include the patient's condition (acute leukemia, neutropenic, fever, and cough), and the treatment options provided (Rifampicin, Valaciclovir, Tigecycline, Voriconazole).
Answer
Voriconazole
The final answer is Voriconazole.
Answer for screen readers
The final answer is Voriconazole.
More Information
Voriconazole is the recommended treatment for invasive aspergillosis, particularly in immunocompromised patients, such as those undergoing bone marrow transplantation.
Tips
A common mistake is to confuse medications needed for bacterial infections or antiviral needs with those for fungal infections.
Sources
- Progress in the diagnosis and management of aspergillosis in bone ... - pubmed.ncbi.nlm.nih.gov
- Invasive Aspergillosis: Case Report and Review of the ... - Lippincott - journals.lww.com
AI-generated content may contain errors. Please verify critical information
